China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19 China Biotech Services Holdings Limited Oct 05, 2020 21:30 HKT/SGT Read More
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc. Document Security Systems, Inc Oct 05, 2020 15:25 HKT/SGT Read More
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread Holista CollTech Ltd Oct 01, 2020 15:00 HKT/SGT Read More
Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea Eisai Sep 30, 2020 14:06 HKT/SGT Read More
知臨集團開設傳染病液體活檢初創子公司,獨家獲得了新加坡Accelerate Technologies的許可以共同開發基於基因組分析以追蹤病原體基因組的快速分子病原體診斷技術 Aptorum Group Limited Sep 29, 2020 18:36 HKT/SGT Read More
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary, Announces Exclusive In-license from Singapore-based Accelerate Technologies to Co-Develop Molecular Based Rapid Pathogen Diagnostics to Track Pathogenic Genome Aptorum Group Limited Sep 29, 2020 18:35 HKT/SGT Read More
Insumate(R)--Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology Greenyn Biotechnology Co. Ltd Sep 28, 2020 16:00 HKT/SGT Read More
Insumate(R)--Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology Greenyn Biotechnology Co. Ltd Sep 28, 2020 15:30 HKT/SGT Read More
노보텍 (Novotech), 파마 인텔리전스 (Pharma Intelligence)의 사이트라인 어워드 2020 (Citeline Awards 2020) 최종후보로 선정 Novotech Health Holdings Pte Ltd Sep 28, 2020 14:00 HKT/SGT Read More
ギリアドとエーザイ、「ジセレカ(R)錠」(一般名:フィルゴチニブマレイン酸塩)について日本で関節リウマチに関する製造販売承認を取得 Eisai Sep 28, 2020 10:00 JST Read More
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay Agilex Biolabs Sep 23, 2020 12:00 HKT/SGT Read More
エーザイ、「レンビマ(R)」(レンバチニブ)と「キイトルーダ(R)」(ペムブロリズマブ)の併用療法について2つの臨床試験から7種のがんに対する初めての臨床データを欧州臨床腫瘍学会年次総会において発表 Eisai Sep 23, 2020 09:00 JST Read More
Eisai Receives Positive Opinion from EMA's CHMP on Use of Antiepileptic Agent Fycompa in Pediatric Patients Eisai Sep 23, 2020 08:24 HKT/SGT Read More
Eisai and Merck Present First-Time Data From Two Studies Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020 Eisai Sep 23, 2020 08:10 HKT/SGT Read More